P933: Closing the internal opening with a rectal advancement flap increases the effectiveness of mesenchymal stem cell (MSC) injection in the treatment of complex Crohn@E@s disease anal fistulasECCO'24Year: 2024
Authors: Fathallah, N.(1)*;O@E@Neill, C.(2);Haouari, M.A.(3);Barré, A.(1);Roland, D.(1);Alam, A.(1);Kassouri, L.(1);Safa Far, E.(1);Spindler, L.(1);de Parades, V.(1);
(1)GH Paris Saint-Joseph, Proctology, Paris, France;(2)Centro Hospitalar de Lisboa Ocidental-Hospital de Egas Moniz, Gastroenterology, Lisboa, Portugal;(3)GH Paris Saint-Joseph, Radiology, Paris, France;
P934: A delphi consensus on the optimisation of medical and surgical therapy in perianal fistulising Crohn’s disease, targeted at individual TOpCLASS classification groupsECCO'24Year: 2024
Authors: Hanna, L.(1)*;Anandabaskaran, S.(2);Iqbal, N.(3);Geldof, J.(4);LeBlanc, J.F.(5);Dige, A.(6);Lundby, L.(7);Bislenghi, G.(8);Verstockt, B.(9);D@E@Hoore, A.(8);Vermeire, S.(9);De Looze, D.(4);Lobaton, T.(4);Van de Putte, D.(10);De Kock, I.(11);Carvello, M.(12);Spinelli, A.(12);Danese, S.(13);Buskens, C.J.(14);Gecse, K.(15);Hompes, R.(14);van der Bilt, J.D.W.(14);Bemelman, W.A.(14);Sebastian, S.(16);Moran, G.W.(17);Lightner, A.(18);Wong, S.Y.(19);Cohen, B.L.(20);Holubar, S.(21);Ding, N.S.(22);Behrenbruch , C.(23);Kapil, S.(3);Misra , R.(1);Lung, P.(24);Hart, A.(1);Tozer, P.(3);
(1)St. Mark@E@s Hospital, Gastroenterology, London, United Kingdom;(2)School of Clinical Medicine- St Vincent’s Healthcare Clinical Campus- University of New South Wales, Gastroenterology, Sydney, Australia;(3)St. Mark@E@s Hospital, Colorectal Surgery, London, United Kingdom;(4)University Hospital Ghent, Gastroenterology, Ghent, Belgium;(5)Hôpital du Sacré-Coeur de Montréal, Gastroenterology, Montreal, Canada;(6)Aarhus University Hospital, Gastroenterology, Aarhus, Denmark;(7)Aarhus University Hospital, Colorectal Surgery, Aarhus, Denmark;(8)University Hospitals of Leuven, Colorectal Surgery, Leuven, Belgium;(9)University Hospitals of Leuven, Gastroenterology, Leuven, Belgium;(10)University Hospital Ghent, Colorectal Surgery, Ghent, Belgium;(11)University Hospital Ghent, Radiology, Ghent, Belgium;(12)Humanitas Research Hospital, Colorectal Surgery, Milan, Italy;(13)Humanitas Research Hospital, Gastroenterology, Milan, Italy;(14)Amsterdam UMC- location AMC, Colorectal Surgery, Amsterdam, The Netherlands;(15)Amsterdam UMC- location AMC, Gastroenterology, Amsterdam, The Netherlands;(16)Hull University Teaching Hospitals, Gastroenterology, Hull, United Kingdom;(17)Nottingham University Hospitals, Gastroenterology, Nottingham, United Kingdom;(18)Scripps Clinic, Colorectal Surgery, San Diego, United States;(19)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(20)Cleveland Clinic, Gastroenterology, Ohio, United States;(21)Cleveland Clinic, Colorectal Surgery, Ohio, United States;(22)St. Vincent’s Hospital, Gastroenterology, Melbourne, Australia;(23)St. Vincent’s Hospital, Colorectal Surgery, Melbourne, Australia;(24)St. Mark@E@s Hospital, Radiology, London, United Kingdom;On behalf of the TOpCLASS perianal Crohn@E@s disease Consortium.
P935: Remission rates of biologics and small molecules in extension studies of moderate to severe Ulcerative Colitis; A systematic review and Network Meta-analysisECCO'24Year: 2024
Authors: Godfrey, D.(1)*;Parkash, N.(1);Segal, J.(1);
(1)The Royal Melbourne Hospital, Gastroenterology, Melbourne, Australia;
P936: Ultrasound Transmural Remission in Crohn@E@s disease: Different Rate between First and Second Line of Biological TherapyECCO'24Year: 2024
Authors: De Sire, R.(1)*;Rispo, A.(1);Caiazzo, A.(1);Cantisani, N.(1);Calabrese, G.(1);Guarino, A.(1);Testa, A.(1);Nardone, O.M.(1);Castiglione, F.(1);
(1)University Federico II of Naples, IBD Unit- Department of Clinical Medicine and Surgery, Naples, Italy;
P937: A Retropective Analysis of Micronutrient Status in Inflammatory Bowel DiseaseECCO'24Year: 2024
Authors: Ruan, G.(1)*;Zhang, Y.(1);Yu, S.(2);Yang, H.(1);
(1)Peking Union Medical College Hospital- Peking Union Medical College & Chinese Academy of Medical Sciences, Department of Gastroenterology, Beijing, China;(2)Peking Union Medical College Hospital- Peking Union Medical College & Chinese Academy of Medical Sciences, Department of Clinical Laboratory, Beijing, China;
P938: Effectiveness and safety of switching from original infliximab to GP1111 biosimilar in inflammatory bowel diseases – prospective, cohort studyECCO'24Year: 2024
Authors: Resál, T.(1)*;Bacsur, P.(1);Pápista, M.(1);Kata, D.(2);Farkas, B.(1);Bálint, A.(1);Fábián, A.(1);Bor, R.(1);Szepes, Z.(1);Farkas, K.(1);Molnár, T.(1);
(1)University of Szeged, Department of Medicine, Szeged, Hungary;(2)University of Szeged, Institution of Laboratory Medicine, Szeged, Hungary;
P939: Ozanimod-Exposed Patients with Ulcerative Colitis Undergoing Total Colectomy Exhibit Unique Histologic Changes in Lymph NodesECCO'24Year: 2024
Authors: Cohen, N.A.(1)*;Weber, C.(2);Cheng, J.(2);Choi, D.(1);Garcia, N.(1);Choi, N.(1);Rubin, D.(1);
(1)University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States;(2)University of Chicago Medicine, Department of Pathology, Chicago, United States;
P940: A glance into paediatric Inflammatory Bowel Disease in Australasia – Crohn’s Colitis Cure (CCC) data insights programECCO'24Year: 2024
Authors: Pipicella, J.L.(1,2,3)*;Dutt, S.(4,5);Giles, E.(6,7);Day, A.S.(8);Wright, R.(9);Goodfellow, T.(10);William, W.(11,12);Andrews, J.M.(2,13,14);Connor, S.J.(1,2,3,15);
(1)University of New South Wales, Medicine & Health South Western Sydney Clinical School, Warwick Farm, Australia;(2)Crohn@E@s Colitis Cure, CCCure, Pyrmont, Australia;(3)Ingham Institute for Applied Medical Research, Gastroenterology- Hepatology and Inflammatory Bowel Disease Research Group, Liverpool, Australia;(4)The Children’s Hospital at Westmead, Department of Gastroenterology, Westmead, Australia;(5)The University of Sydney, Children’s Hospital Westmead Clinical School, Sydney, Australia;(6)Monash University, Department of Paediatrics, Clayton, Australia;(7)Hudson Institute of Medical Research, Centre for Innate Immunity and Infectious Disease, Clayton, Australia;(8)University of Otago Christchurch, Department of Paediatrics, Christchurch, New Zealand;(9)Department of Paediatrics, University of Otago, Christchurch, New Zealand;(10)SA Health, Department of Health and Wellbeing- Office of the Chief Medical Information Officer, Adelaide, New Zealand;(11)Lyell McEwin Hospital, Anaesthetics, Adelaide, Australia;(12)SA Health, Chief Medical Information Officer, Adelaide, Australia;(13)Central Adelaide Local Health Network, Gastroenterology, Adelaide, Australia;(14)The University of Adelaide, Faculty of Health Sciences, Adelaide, Australia;(15)Liverpool Hospital, Gastroenterology and Hepatology, Liverpool, Australia;
P941: Observational study of tofacitinib in ulcerative colitis in Sweden (ODEN) – Interim analysis of clinical and biomarker dataECCO'24Year: 2024
Authors: Nyberg, L.(1,2);Söderling, J.(3);Olén, O.(3);Strid, H.(4);Jäghult, S.(5);Halfvarson, J.(6);Hedin, C.(7);Jónsdóttir, S.(4);Hjortswang, H.(8);Cappelleri, J.(9);Henrohn, D.(10,11);Seddighzadeh, M.(10);Marsal, J.(2,12);Grip, O.(12)*;
(1)Skåne University Hospital, Department of Gastroentrology, Malmö, Sweden;(2)Lund University, Department of Clinical Sciences, Lund, Sweden;(3)Karolinska Institutet, Clinical Epidemiology, Stockholm, Sweden;(4)Karolinska University Hospital, Department of Gastroenterology, Stockholm, Sweden;(5)Karolinska Institutet, Department of Clinical Sciences, Stockholm, Sweden;(6)Örebro University, Institute of Medical Sciences, Örebro, Sweden;(7)Karolinska institutet, Department of Medicine, Stockholm, Sweden;(8)University of Linköping, Department of Clinical and Experimental Medicine, Linköping, Sweden;(9)Pfizer Inc, Statistical Research and Data Science Center, Groton- Connecticut, United States;(10)Pfizer AB, Department of Medical Affairs, Stockholm, Sweden;(11)University of Uppsala, Department of Medical Sciences, Uppsala, Sweden;(12)Skane University Hospital, Department of Gastroenterology, Lund/Malmö, Sweden;SWIBRED ODEN Study group
P942: Real-world data on outcomes of treatment with ustekinumab in patients with Ulcerative ColitisECCO'24Year: 2024
Authors: Chalakatevaki, K.(1)*;Kokkotis, G.(1);Chatzinikolaou, M.L.(1);Anagnostopoulou, E.(2);Argiriou, K.(3);Viazis, N.(4);Galanopoulos, M.(5);Gerasimatos, G.(6);Giouleme, O.(7);Zampeli, E.(8);Zacharopoulou, E.(9);Theodoropoulou, A.(10);Theocharis, G.(11);Kalogirou, M.(7);Karatzas, P.(12);Karmiris, K.(10);Kapsoritakis, A.(3);Koustenis, K.(4);Koutroumpakis, I.(13);Kiriakos, N.(5);Lazou, D.(14);Liatsos, C.(5);Mantaka, A.(2);Mantzaris, G.(4);Michalopoulos, G.(6);Michopoulos, S.(8);Orfanidou, A.(12);Papathanasiou, E.(8);Polymeros, D.(15);Potamianos, S.(3);Sotiropoulos, C.(11);Soufleris, K.(14);Tzouvala, M.(9);Foteinogiannopoulou, K.(13);Chatzidakis, A.(15);Psistakis, A.(10);Bamias, G.(1);
(1)3rd Academic Department of Internal Medicine, University of Athens- Sotiria Hospital- GI Unit, Athens, Greece;(2)Saint George General Hospital of Chania, Department of Gastroenterology, Chania- Crete, Greece;(3)University General Hospital of Larissa, Department of Gastroenterology, Larissa, Greece;(4)Evangelismos Hospital, Department of Gastroenterology, Athens, Greece;(5)401 General Military Hospital, Department of Gastroenterology, Athens, Greece;(6)General Hospital G. Gennimatas, Department of Gastroenterology, Athens, Greece;(7)Aristotle University of Thessaloniki, 2nd Propedeutic Department of Internal Medicine, Thessaloniki, Greece;(8)General Hospital Alexandra, Department of Gastroenterology, Athens, Greece;(9)General Hospital of Nikea and Pireaus, Department of Gastroenterology, Athens, Greece;(10)Venizeleio General Hospital, Department of Gastroenterology, Heraklion- Crete, Greece;(11)General University Hospital of Patras, Department of Gastroenterology, Patras, Greece;(12)General Hospital Laiko, Department of Gastroenterology, Athens, Greece;(13)University General Hospital of Heraklion, Department of Gastroenterology, Heraklion- Crete, Greece;(14)Theagenio Cancer Hospital of Thessaloniki, Department of Gastroenterology, Thessaloniki, Greece;(15)Attikon University Hospital, Department of Gastroenterology, Athens, Greece;
P943: Real world Effectiveness and safety of tofacitinib in patients with Ulcerative Colitis: 6 months follow-up of the French TOFAST studyECCO'24Year: 2024
Authors: Fumery, M.(1)*;Bouhnik, Y.(2);Faure, P.(3);Bouzidi, A.(4);Brault, Y.(5);Peyrin-Boroulet, L.(6);Laharie, D.(7);
(1)University Hospital of Amiens, Gastroenterology and Hepatology Unit, Amiens, France;(2)Clinique Ambroise-Paré, Institut des MICI-, Neuilly-Sur-Seine, France;(3)Clinique Pasteur, Gastroenterology, Toulouse, France;(4)Pfizer France, Immunologie and Inflammation, Paris, France;(5)Pfizer France, Inflammation and Immunology, Paris, France;(6)IHU Infinity, IBD Unit, Nancy, France;(7)University hopital of Bordeaux, Gastroenterology and Hepatology Unit, Bordeaux, France;
P944: Ustekinumab in refractory Ulcerative Colitis: single-center, real-world experienceECCO'24Year: 2024
Authors: Herrera De Guise, C.M.(1)*;Mayorga Ayala, L.F.(1);Robles Alonso, V.(1);Serra Ruiz, X.(1);Céspedes Martínez, E.(1);Lastiri Gonzalez, E.(1);Pérez Martínez, Z.(1);Oller Jimenez, E.(1);Casellas, F.(1);Borruel Sainz, N.(1);
(1)Unitat d@E@Atenció Crohn-Colitis- Hospital Universitari Vall d@E@Hebron, Gastroenterology, Barcelona, Spain;
P945: Crohn´s disease response to ustekinumab measured by bowel ultrasoundECCO'24Year: 2024
Authors: Navarro-Gerrard, C.(1);Bastón Rey, I.(1)*;González López, J.(2);Ferreiro Iglesias, R.(1);Sequeiros Portela, M.D.(1);Dominguez Munoz, J.E.(1);Barreiro de Acosta, M.(1);
(1)University Hospital Santiago de Compostela CHUS, Gastroenterology, Santiago de Compostela, Spain;(2)University Hospital Santiago de Compostela CHUS, Pharmacy, Santiago de Compostela, Spain;
P946: Real life management of patients with active perianal fistulizing Crohn’s disease (ALERT-CD study)ECCO'24Year: 2024
Authors: Bak, M.(1)*;Stassen, L.(2);Buskens, C.(3);Pronk, A.(3);van der Bilt, J.(4);Gecse, K.(5);de Boer, N.(5);Witjes, C.(6);Fitzpatrick, C.(7);Nissen, L.(8);Verdaasdonk, E.(9);Pierik, M.(10);Breukink, S.(2);Gillissen, L.(11);Bloemen, J.(12);West, R.(13);Kortekaas, R.(14);Mares, W.(15);de Jong, G.(16);Jansen, S.(17);Bloemendaal, B.(18);Sikkema, M.(19);Zimmerman, D.(20);Peeters, K.(21);van der Meulen- de Jong, A.(22);van Schaik, F.(23);Richir, M.(24);van Dongen , K.(25);Duijvestein, M.(26);Hoogenboom, F.(27);Visschedijk, M.(28);de Vries, A.(1);van Ruler, O.(6);
(1)Erasmus University Medical Center Rotterdam, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(2)Maastricht University Medical Center, Department of Surgery, Maastricht, The Netherlands;(3)Amsterdam University Medical Center, Department of Surgery, Amsterdam, The Netherlands;(4)Flevoziekenhuis, Department of Surgery, Almere, The Netherlands;(5)Amsterdam University Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(6)IJsselland Hospital, Department of Surgery, Capelle aan den IJssel, The Netherlands;(7)IJsselland Hospital, Department of Gastroenterology and Hepatology, Capelle aan den IJssel, The Netherlands;(8)Jeroen Bosch Hospital, Department of Gastroenterology and Hepatology, @E@s Hertogenbosch, The Netherlands;(9)Jeroen Bosch Hospital, Department of Surgery, @E@s Hertogenbosch, The Netherlands;(10)Maastricht University Medical Center, Department of Gastroenterology and Hepatology, Maastricht, The Netherlands;(11)Catharina Hospital, Department of Gastroenterology and Hepatology, Eindhoven, The Netherlands;(12)Catharina Hospital, Department of Surgery, Eindhoven, The Netherlands;(13)Franciscus Gasthuis & Vlietland, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(14)Franciscus Gasthuis & Vlietland, Department of Surgery, Rotterdam, The Netherlands;(15)Gelderse Vallei, Department of Gastroenterology and Hepatology, Ede, The Netherlands;(16)Gelderse Vallei, Department of Surgery, Ede, The Netherlands;(17)Reinier de Graaf Groep, Department of Gastroenterology and Hepatology, Delft, The Netherlands;(18)Reinier de Graaf Groep, Department of Surgery, Delft, The Netherlands;(19)Elisabeth TweeSteden Hospital, Department of Gastroenterology and Hepatology, Tilburg, The Netherlands;(20)Elisabeth TweeSteden Hospital, Department of Surgery, Tilburg, The Netherlands;(21)Leiden University Medical Center, Department of Surgery, Leiden, The Netherlands;(22)Leiden University Medical Center, Department of Gastroenterology and Hepatology, Leiden, The Netherlands;(23)University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht, The Netherlands;(24)University Medical Center Utrecht, Department of Surgery, Utrecht, The Netherlands;(25)Maasziekenhuis Pantein, Department of Surgery, Boxmeer, The Netherlands;(26)RadboudUMC, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(27)University Medical Center Groningen, Department of Surgery, Groningen, The Netherlands;(28)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;on behalf of the ALERT-CD study group on behalf of the Dutch Initiative on Crohn and Colitis – Surgery (ICC-S) and Dutch Initiative on Crohn and Colitis (ICC)
P947: medical cannabis increases appetite but not body weight in patients with inflammatory bowel diseasesECCO'24Year: 2024
Authors: Fliss Isakov, N.(1);Seidenberg, C.(2);Meiri, D.(3);Yackobovitch-Gavan, M.(4);Maharshak, N.(1);Hirsch, A.(5)*;
(1)Tel Aviv Medical Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel;(2)Hebrew University of Jerusalem, School of Pharmacy, Jerusalem, Israel;(3)Technion- Israel Institute of Technology, The Laboratory of Cancer Biology and Natural Drug Discovery- Faculty of Biology, Haifa, Israel;(4)Tel Aviv University, Dept. of Epidemiology and Preventive Medicine- School of Public Health- Faculty of Medicine, Tel Aviv, Israel;(5)Tel Aviv Medical Center, Department of Gastroenterology, Tel Aviv, Israel;
P948: Hand Grip Strength is a useful objective measure associated with fatigue and impaired quality of life in patients with inflammatory bowel diseaseECCO'24Year: 2024
Authors: Stack, R.(1,2)*;Ní Chonnacháin, C.(3,4);Doherty, J.(1,2);O@E@Moran, N.(1,2);Girod, P.(1);Noronha, N.(3,4);Gibney, E.R.(3,4);Doherty, G.A.(1,2);
(1)St. Vincent@E@s University Hospital, Gastroenterology, Dublin, Ireland;(2)University College Dublin, School of Medicine, Dublin, Ireland;(3)University College Dublin, Institute of Food and Health, Dublin, Ireland;(4)University College Dublin, Food for Health Ireland, Dublin, Ireland;
P949: Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study. A multicenter study from the young group of GETECCU.ECCO'24Year: 2024
Authors: Fuentes-Valenzuela, E.(1)*;Bastón-Rey, I.(2);García-Alonso, F.J.(1);Leo Carnerero , E.(3); Garcia de la Filia, I.(4);Pedraza Pérez, A.(5);Sáiz Chumillas, R.M.(6);Pascual Oliver, A.(7);Muñoz Villafranca, C.(8);Moreno, V.(9);Suárez Ferrer, C.(10);Molina Arriero, G.(11);Ferreiro-Iglesias, R.(12);Vega Villaamil, P.(13);Gardeazábal Mateos, D.(14);Segarra-Ortega, J.X.(15);Garrido Marín, A.(16);Doallo, A.I.(17);Elosua, A.(18);Alonso-Galán, H.(19);Brunet- Mas, E.(20);Jimenez García, N.(21);López Romero-Salazar , F.(22);Velayos, B.(23);Carballo-Folgoso, L.(24);Pérez Santamaría, C.(25);Mata Román, L.(26);Núñez Ortiz, A.(3);Barrio, J.(1);Barreiro-de Acosta, M.(2);Gutiérrez-Casbas, A.(9);
(1)Hospital Universitario Rio Hortega, Gastroenterology Department., Valladolid, Spain;(2)Hospital Clínico de Santiago- Fundación Instituto de Investigación Sanitaria de Santiago de Compostela FIDIS, Gastroenterology Department., Santiago de Compostela, Spain;(3)Hospital Universitario Virgen del Rocío, Gastroenterology Department., Sevilla, Spain;(4)Hospital Universitario Ramón y Cajal, Gastroenterology Department., Madrid, Spain;(5)Hospital Universitario de Álava, Gastroenterology Department, Vitoria, Spain;(6)Hospital Universitario de Burgos, Gastroenterology Department, Burgos, Spain;(7)Hospital Universitario Miguel Servet, Gastroenterology Department., Zaragoza, Spain;(8)Hospital Universitario de Basurto, Gastroenterology Department., Bilbao, Spain;(9)Hospital General Universitario de Alicante- ISABIAL. CIBERehd, Gastroenterology Department., Alicante, Spain;(10)Hospital Universitario La Paz, Gastroenterology Department., Madrid, Spain;(11)Complejo Hospitalario Universitario de Ferrol, Gastroenterology Department., Ferrol, Spain;(12)Hospital Clínico de Santiago- Fundación Instituto de Investigación Sanitaria de Santiago de Compostela FIDIS, Gastroenterology Department, Santiago de Compostela, Spain;(13)Complexo Hospitalario Universitario de Ourense, Gastroenterology Department., Ourense, Spain;(14)Hospital Universitario de Galdakao, Galdakao, Galdakao, Spain;(15)Hospital Universitario de Salamanca, Gastroenterology Department., Salamanca, Spain;(16)Hospital Universitario La Fe, Gastroenterology Department., Valencia, Spain;(17)Complejo Hospitalario Universitario de Vigo, Gastroenterology Department., Vigo, Spain;(18)Hospital de García Orcoyen, Gastroenterology Department., Estella, Spain;(19)Hospital Universitario de Donostia- Instituto Biogipuzkoa, Gastroenterology Department., Donostia, Spain;(20)Hospital Parc Tauli, Gastroenterology Department., Sabadell, Spain;(21)Hospital Universitario de Elche, Gastroenterology Department., Elche, Spain;(22)Hospital Universitario 12 de Octubre, Gastroenterology Department., Madrid, Spain;(23)Hospital Clínico Universitario de Valladolid, Gastroenterology Department., Valladolid, Spain;(24)Hospital Universitario Central de Asturias, Gastroenterology Department., Oviedo, Spain;(25)Hospital Universitario de Móstoles, Gastroenterology Department., Mósteles, Spain;(26)Hospital de Medina del Campo, Gastroenterology Department., Medina del Campo, Spain;
P950: Advancing Precision Nutritional Assessment in Inflammatory Bowel Disease (IBD): Adding Fecal Calprotectin in the Malnutrition Inflammation Risk Tool (MIRT) scoreECCO'24Year: 2024
Authors: Dhoble, P.(1)*;Desai, D.(1);Abraham , P.(1);Gupta, T.(1);Dharap, V.(1);Kutar, M.(1);
(1)P D Hinduja Hospital and Medical Research Centre- Mumbai, Medical Gastroenterology, Mumbai, India;
P951: Efficacy and safety of tofacitinib for the treatment of moderate- severe ulcerative colitis in biologic naïve patientsECCO'24Year: 2024
Authors: Liatsos, C.(1)*;Michalopoulos, G.(2);Tzouvala, M.(3);Giouleme, O.(4);Kozompoli, D.(5);Mousourakis, K.(5);Kyriakos, N.(1);Giakoumis, M.(1);Striki, A.(2);Karoumpalis, I.(2);Bellou, G.(3);Zacharopoulou, E.(3);Katsoula, A.(4);Kalogirou, M.(4);Viazis, N.(5);
(1)401 General Military Hospital of Athens, Gastroenterology, Athens, Greece;(2)G. Genimatas- General Hospital, Gastroenterology, Athens, Greece;(3)General Hospital Nikaias-Piraeus, Gastroenterology, Athens, Greece;(4)General Hospital “Hippokratio, 2nd Propaedeutic Department of Internal Medicine, Thessaloniki, Greece;(5)Evangelismos General Hospital, Gastroenterology, Athens, Greece;
P952: Why do patients with Inflammatory Bowel Disease Take Part in Pharmaceutical Clinical Trials? A qualitative study of Clinical Trial ParticipantsECCO'24Year: 2024
Authors: Solitano, V.(1)*;Prins, H.(1);Archer, M.(1);Guizzetti, L.(2);Jairath, V.(1,3);
(1)Western University, Division of Gastroenterology- Department of Medicine, London- Ontario, Canada;(2)Independent Researcher, Independent Researcher, London- Ontario, Canada;(3)Western University, Department of Epidemiology and Biostatistics, London- Ontario, Canada;